Biogen (BIIB) PT Raised to $435 at JPMorgan
Get Alerts BIIB Hot Sheet
Price: $221.56 +4.24%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
JPMorgan analyst Cory Kasimov raised the price target on Biogen (NASDAQ: BIIB) to $435.00 (from $269.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Kingsoft Cloud (KC) PT Raised to $17.70 at Jefferies
- Morgan Stanley Upgrades Suncor Energy (SU) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share